Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus

This publication has 22 references indexed in Scilit:

• Efficacy of Quinupristin-Dalfopristin against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Insensitive S. aureus in a Model of Hematogenous Pulmonary Infection
  Chemotherapy, 2004
• Effects ofDQ-113, a New Quinolone, against Methicillin- and Vancomycin-Resistant Staphylococcus aureus -Caused Hematogenous PulmonaryInfections inMice
  Antimicrobial Agents and Chemotherapy, 2003
• Infection with Vancomycin-ResistantStaphylococcus aureusContaining thevanAResistance Gene
  New England Journal of Medicine, 2003
• Efficacy of Linezolid against Methicillin-Resistant or Vancomycin-Insensitive Staphylococcus aureus in a Model of Hematogenous Pulmonary Infection
  Antimicrobial Agents and Chemotherapy, 2002
• In Vitro Antibacterial Activities of DQ-113, a Potent Quinolone, against Clinical Isolates
  Antimicrobial Agents and Chemotherapy, 2002
• Linezolid resistance in a clinical isolate of Staphylococcus aureus
  The Lancet, 2001
• Bactericidal Activity of Quinupristin-Dalfopristin against Staphylococcus aureus : Clindamycin Susceptibility as a Surrogate Indicator
  Antimicrobial Agents and Chemotherapy, 2000
• In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant Strains
  Antimicrobial Agents and Chemotherapy, 2000
• Emergence of Vancomycin Resistance inStaphylococcus aureus
  New England Journal of Medicine, 1999
• Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
  Journal of Antimicrobial Chemotherapy, 1997